See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-98. The Impact of Effective Aortic Annulus Sizing by 3D Computed Tomography on Paravalvular Leak Development After Transcatheter Aortic Valve Implantation

Presenter: Fabian Plank

October 23, 2012

Presentation TCT 2012

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

Imaging Guidance for MitraClip Eligibility and Implantation: Top 10 Tips and Tricks

Presenter: Paul Grayburn

October 23, 2012

Presentation TCT 2012

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

Essentials of 2-D and 3-D Mitral Valve Imaging

Presenter: Nina Wunderlich

October 23, 2012

Presentation TCT 2012

ELM Presentation(9)

Presenter: Jennifer Tremmel

October 23, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

History of SCAI and CCI

Presenter: Frank Hildner

October 23, 2012

Presentation TCT 2012

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Presenter: Thomas McNamara

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

Presenter: Mehdi Shishehbor

October 23, 2012

Advertisement

Slides

TCT-98. The Impact of Effective Aortic Annulus Sizing by 3D Computed Tomography on Paravalvular Leak Development After Transcatheter Aortic Valve Implantation

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Imaging Guidance for MitraClip Eligibility and Implantation: Top 10 Tips and Tricks

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

Essentials of 2-D and 3-D Mitral Valve Imaging

ELM Presentation(9)

Autologous Cardiac Stem Cells in VAD Patients

History of SCAI and CCI

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content